Abstract
The use of organocatalysis has simplified and increased the potential of synthetic approaches to natural products. Different aspects, regarding applications and even perspectives of iminium- or enamine-catalysis have been studied in this increasingly developing area during the past decades. Addressing those features, this article aims to give an overview through selected examples, focusing on discussing academic insights of a variety of key reactions such as aldol and Mannich reactions, and 1,4-conjugated additions, as well as applications to the synthesis of natural products, in the period 2012-to date.
Keywords: 1, 4-conjugated addition, aldol reaction, asymmetric synthesis, enamine-activation, mannich reaction, natural products, organocatalysis.
Graphical Abstract
Current Organocatalysis
Title:Organocatalysis in the Synthesis of Natural Products: Recent Developments in Aldol and Mannich Reactions, and 1,4-Conjugated Additions
Volume: 2 Issue: 2
Author(s): Estefania Dibello, Daniela Gamenara and Gustavo Seoane
Affiliation:
Keywords: 1, 4-conjugated addition, aldol reaction, asymmetric synthesis, enamine-activation, mannich reaction, natural products, organocatalysis.
Abstract: The use of organocatalysis has simplified and increased the potential of synthetic approaches to natural products. Different aspects, regarding applications and even perspectives of iminium- or enamine-catalysis have been studied in this increasingly developing area during the past decades. Addressing those features, this article aims to give an overview through selected examples, focusing on discussing academic insights of a variety of key reactions such as aldol and Mannich reactions, and 1,4-conjugated additions, as well as applications to the synthesis of natural products, in the period 2012-to date.
Export Options
About this article
Cite this article as:
Dibello Estefania, Gamenara Daniela and Seoane Gustavo, Organocatalysis in the Synthesis of Natural Products: Recent Developments in Aldol and Mannich Reactions, and 1,4-Conjugated Additions, Current Organocatalysis 2015; 2 (2) . https://dx.doi.org/10.2174/2213337202666150516001331
DOI https://dx.doi.org/10.2174/2213337202666150516001331 |
Print ISSN 2213-3372 |
Publisher Name Bentham Science Publisher |
Online ISSN 2213-3380 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Herb-Drug Interactions: An Evidence Based Approach
Current Medicinal Chemistry NKT Cell Subsets Can Exert Opposing Effects in Autoimmunity, Tumor Surveillance and Inflammation
Current Immunology Reviews (Discontinued) G Protein-Coupled Receptors in Regulation of Body Weight
CNS & Neurological Disorders - Drug Targets Why Anticancer Nanomedicine Needs Sugars?
Current Medicinal Chemistry Functionalized Carbon Nano-scale Drug Delivery Systems From Biowaste Sago Bark For Cancer Cell Imaging
Current Drug Delivery Preventing and Treating Anthracycline-Related Cardiotoxicity in Survivors of Childhood Cancer
Current Cancer Therapy Reviews Biochemical and Pharmacological Applications of Essential Oils in Human Health Especially in Cancer Prevention
Anti-Cancer Agents in Medicinal Chemistry Heterocyclic Analogues as Kinase Inhibitors: A Focus Review
Current Topics in Medicinal Chemistry Activin Receptor-Like Kinase 1: a Novel Anti-angiogenesis Target from TGF-β Family
Mini-Reviews in Medicinal Chemistry NAD<sup>+</sup>-Dependent Enzymes at the Endoplasmic Reticulum
Current Topics in Medicinal Chemistry Advances in Immunotherapy of Chronic Myeloid Leukemia CML
Current Cancer Drug Targets Strategies to Improve the Killing of Tumors Using Temozolomide: Targeting the DNA Repair Protein MGMT
Current Medicinal Chemistry ACP5: Its Structure, Distribution, Regulation and Novel Functions
Anti-Cancer Agents in Medicinal Chemistry TRAIL Gene Therapy: From Preclinical Development to Clinical Application
Current Gene Therapy Phenolic Compounds as Nutraceuticals or Functional Food Ingredients
Current Pharmaceutical Design Iron Chelators as Anti-Neoplastic Agents: Current Developments and Promise of the PIH Class of Chelators
Current Medicinal Chemistry Melatonin Induces Apoptosis and Inhibits the Proliferation of Cancer Cells via Reactive Oxygen Species-mediated MAPK and mTOR Pathways
Clinical Cancer Drugs DNA Drug Design for Cancer Therapy
Current Pharmaceutical Design Recent Developments in Targeting Breast Cancer Stem Cells
Recent Patents on Regenerative Medicine Macromolecular Drug Targets in Cancer Treatment and Thiosemicarbazides as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry